GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's other current liabilities for the quarter that ended in Jun. 2014 was $0.64 Mil.
Synageva BioPharma Corp's quarterly other current liabilities increased from Dec. 2013 ($0.23 Mil) to Mar. 2014 ($0.75 Mil) but then declined from Mar. 2014 ($0.75 Mil) to Jun. 2014 ($0.64 Mil).
Synageva BioPharma Corp's annual other current liabilities increased from Dec. 2011 ($2.20 Mil) to Dec. 2012 ($5.39 Mil) but then declined from Dec. 2012 ($5.39 Mil) to Dec. 2013 ($0.23 Mil).
The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.
Synageva BioPharma Corp Annual Data
|Other Current Liab.||2.19||1.72||2.12||0.27||0.27||0.27||0.00||2.20||5.39||0.23|
Synageva BioPharma Corp Quarterly Data
|Other Current Liab.||12.38||10.48||7.69||5.39||2.47||2.15||1.84||0.23||0.75||0.64|